Claigan Webinar - New EU MDR CMRs and Allergens - Preparing for 50 new in-scope substances by 2028

OTTAWA, ON, March 31, 2026 /PRNewswire/ - On April 8th, Claigan will present a webinar focusing on a major update to substances in scope of the EU Medical Device Regulation (EU MDR). To maintain EU market access by 2028, device registrations must account for forty (40) new Carcinogens,...